Longitudinal follow-up of "benign" multiple sclerosis at 20 years

被引:104
|
作者
Sayao, Ana-Luiza [1 ]
Devonshire, Virginia [1 ]
Tremlett, Helen [1 ]
机构
[1] Univ British Columbia, Dept Med Neurol, Vancouver, BC V6T 2B5, Canada
关键词
D O I
10.1212/01.wnl.0000253185.03943.66
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To evaluate disease status after 20 years in a cohort defined as "benign multiple sclerosis (MS)" (Expanded Disability Status Scale [EDSS] score <= 3) at 10 years from onset. Methods: Patients with an EDSS score <= 3 at 10 (+/- 1) years from onset were selected from the British Columbia MS clinic database. The 20-year EDSS score was the primary outcome. Potential risk factors differentiating those who " continued benign" (EDSS score <= 3.0) from those who were "no longer benign" (EDSS score > 3.0) at 20 years, including age at onset, onset symptoms, and 10-year EDSS score, were analyzed, and lower 10-year EDSS score cutoffs were investigated. Results: Twenty-year EDSS scores were obtained for 169 of 200 patients (84.5%); of these, 88 (52.1%) continued benign, but 36 (21.3%) progressed to require the use of a cane (EDSS score >= 6). Conversion to secondary progressive MS occurred in 45 of 196 patients (23%) with a relapsing remitting onset. The only variable associated with disease progression at 20 years was the 10-year EDSS score (p < 0.0005); no 10-year EDSS score seemed ideal in predicting benign status, and an EDSS score <= 2 resulted in 32% becoming no longer benign. Discussion: At 10 years from onset, neither an Expanded Disability Status Scale ( EDSS) score <= 3 nor an EDSS score <= 2 adequately represented "benign multiple sclerosis (MS)" because an appreciable proportion of patients progressed in disease severity. Appropriate and reliable criteria to identify which patients with MS remain with mild disability over the long term have yet to be determined.
引用
收藏
页码:496 / 500
页数:5
相关论文
共 50 条
  • [31] Clinical characteristics of secondary progressive multiple sclerosis - a 10 years follow-up study
    Deisenhammer, F.
    Schmidauer, M.
    Bsteh, G.
    Hegen, H.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 783 - 783
  • [32] Natalizumab treatment of multiple sclerosis in Denmark - a nationwide study with 14 years of follow-up
    Buron, M. D.
    Christensen, J. R.
    Joensen, H.
    Kant, M.
    Rasmussen, P. V.
    Sellebjerg, F.
    Sorensen, P. S.
    Pontieri, L.
    Magyari, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 380 - 381
  • [33] Disease trajectory in secondary progressive multiple sclerosis: a ten years follow-up study
    D'Amico, E.
    Zanghi, A.
    Lo Fermo, S.
    Zappia, M.
    Patti, F.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 199 - 199
  • [34] PROGNOSTIC FACTORS IN A MULTIPLE-SCLEROSIS INCIDENCE COHORT WITH 25 YEARS OF FOLLOW-UP
    RUNMARKER, B
    ANDERSEN, O
    [J]. BRAIN, 1993, 116 : 117 - 134
  • [35] CRYOSURGERY FOR BENIGN CERVICITIS WITH FOLLOW-UP OF 6 AND A HALF YEARS
    COLLINS, RJ
    PAPPAS, HJ
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1972, 113 (06) : 744 - &
  • [36] BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS - 25 YEARS OF FOLLOW-UP
    PUTTERMAN, C
    KEIDAR, S
    BROOK, JG
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1987, 63 (738) : 295 - 296
  • [37] Longitudinal 7-year follow-up of chronic pain in persons with multiple sclerosis in the community
    Fary Khan
    Bhasker Amatya
    Jürg Kesselring
    [J]. Journal of Neurology, 2013, 260 : 2005 - 2015
  • [38] Longitudinal 7-year follow-up of chronic pain in persons with multiple sclerosis in the community
    Khan, Fary
    Amatya, Bhasker
    Kesselring, Juerg
    [J]. JOURNAL OF NEUROLOGY, 2013, 260 (08) : 2005 - 2015
  • [39] Longitudinal assessment of brain lesion changes in follow-up MRI scans of patients with multiple sclerosis
    Jain, S.
    Ribbens, A.
    Sima, D. M.
    Cambron, M.
    De Keyser, J.
    Wang, C.
    Barnett, M. H.
    Van Huffel, S.
    Maes, F.
    Maertens, A.
    Smeets, D.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 528 - 529
  • [40] FOLLOW-UP STUDY ON CORTICOTROPHIN TREATMENT OF MULTIPLE SCLEROSIS
    CENDROWS.WS
    [J]. PSYCHIATRIA ET NEUROLOGIA, 1967, 154 (02): : 65 - &